Story
Credo Technology Stock Rallies on Analyst Upgrades, AI Product Showcase

Summary
Shares of Credo Technology (CRDO) surged after a series of positive analyst notes and the company's showcase of its AI-focused optical solutions at a major industry conference provided a tailwind for the stock.
Credo Technology (NASDAQ: CRDO) stock rallied sharply in Thursday's morning session, gaining 6.0% to reach $186.49. The surge was driven by a confluence of positive analyst commentary and the company's prominent role at a key industry conference, set against a supportive broader market.
Analyst Actions Signal Confidence
Investor sentiment was bolstered by several constructive actions from Wall Street analysts. Key developments included:
- Mizuho: Maintained its "Outperform" rating. While the firm trimmed its price target to $245 from $290 to reflect lower peer-group multiples, it noted that its post-earnings channel checks remain positive, pointing to strong Amazon ramps in 2027 and growing engagement with other major cloud providers.
- Rosenblatt: Lifted its price target on the stock to $235 from a previous $215.
- Other Commentary: A new "Buy" rating was also initiated, according to Investing.com. Another analyst report argued that the stock was significantly mispriced, trading roughly 43% below its 52-week high despite posting 115% revenue growth.
AI Infrastructure in the Spotlight
AdThe rally coincided with Credo's participation in ECOC 2026, a major optical networking conference in Málaga, Spain. At the event, the company is showcasing its 1.6T optical connectivity solutions, which are designed for the high-bandwidth demands of AI scale-out infrastructure.
This showcase highlights Credo's strategic pivot from copper-based active electrical cables to a vertically integrated optical platform. Analysts see this transition as a critical long-term growth driver, positioning the company to capitalize on the build-out of data centers for artificial intelligence.
Market Context
The move higher was supported by a bullish tone in the broader market, with the tech-heavy NASDAQ Composite rising 1.4% and the S&P 500 gaining 0.9%. The positive momentum for Credo comes after a significant pullback from its 52-week high of $308.67, prompting investors to reassess its valuation amid the positive catalysts.
Read next
More on Stocks
Laekna's Cancer Drug Opatisumimab Earns Late-Breaking Abstract Status at ESMO Congress
Laekna announced its pivotal Phase IIb study for the bispecific antibody opatisumimab in late-stage neuroendocrine carcinoma has been selected for a Late-Breaking Abstract oral presentation at the European Society for Medical Oncology Congress. The company will also present findings from two other studies in proffered oral sessions.

Huatai Securities Raises RMB 1.9 Billion in Oversubscribed Perpetual Bond Sale
The Chinese brokerage secured a 1.85% coupon rate on the perpetual subordinated bonds, which saw strong demand with a subscription ratio of 4.77 times from professional investors.

Crypto-Linked Stocks Rally as Bitcoin Surges Past $85,000
Shares of companies with exposure to the cryptocurrency market, including MicroStrategy and Coinbase, gained on Monday after Bitcoin's price climbed more than 5% to break the $85,000 threshold.

Optical Communication Stocks Rise as AI-Focused ECOC Conference Begins
Shares of companies like Astera Labs and Corning rallied Monday, driven by investor optimism around new technologies for AI data centers being presented at the ECOC 2026 conference in Spain.